OKYO Pharma Ltd (OKYO) stock
OKYONasdaqBiological Products, (No Diagnostic Substances)
$1.17−0.18 (-13.33%)
Close on Nov 16, 2026Market cap $61.40MP/E –Yield –
OKYO Pharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2026 it was -$5.94M. The highest annual figure on record is -$1.20M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$5.94M | – |
| FY2025 | Mar 31, 2025 | -$1.81M | – |
| FY2024 | Mar 31, 2024 | -$9.49M | – |
| FY2023 | Mar 31, 2023 | -$7.70M | – |
| FY2022 | Mar 31, 2022 | -$5.47M | – |
| FY2021 | Mar 31, 2021 | -$1.60M | – |
| FY2020 | Mar 31, 2020 | -$1.20M | – |
See a number that looks wrong?